There seems to be an appetite for growth in “Big Pharma” strategies right now.
So, hopefully, Herantis Pharma can secure a good deal and bring some brisk pace to their drug development.
It probably would have been good to get the Michael J. Fox Foundation involved to represent those suffering from Parkinson’s and other movement disorders.